Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 55.84B | 8.57%54B | 7.83%210.75B | 8.20%53.56B | 8.15%49.74B | 12.26%195.44B | 11.21%50.9B | 13.77%49.06B | 13.63%49.5B | 10.41%45.99B |
| Cost of revenue | 40.36B | 9.54%39.17B | 7.91%152.25B | 8.43%38.93B | 7.83%35.76B | 11.89%141.09B | 10.62%36.54B | 13.87%35.49B | 13.16%35.9B | 9.88%33.16B |
| Gross profit | 15.48B | 6.06%14.82B | 7.64%58.5B | 7.58%14.63B | 8.95%13.97B | 13.23%54.35B | 12.71%14.36B | 13.50%13.56B | 14.88%13.6B | 11.81%12.83B |
| Operating expense | 12.49B | 6.81%11.77B | 6.32%46.22B | 7.48%11.83B | 6.24%11.02B | 11.64%43.47B | 9.60%11.24B | 11.79%10.86B | 13.78%11B | 11.49%10.37B |
| Staff costs | --5.99B | 9.78%5.63B | 10.74%21.68B | 13.51%5.51B | 9.43%5.13B | 11.95%19.57B | 10.67%5.02B | 15.68%5.01B | 12.28%4.86B | 9.20%4.69B |
| Selling and administrative expenses | --1.8B | -0.41%1.68B | 0.22%7.32B | -3.32%2.01B | -5.06%1.69B | 6.39%7.3B | -6.19%1.73B | -5.65%1.72B | 20.73%2.08B | 20.22%1.78B |
| -Selling and marketing expense | --383M | 11.34%383M | 1.67%1.4B | -27.53%329M | -10.65%344M | 5.67%1.38B | -0.28%352M | -45.00%187M | 56.55%454M | 19.94%385M |
| -General and administrative expense | --1.42B | -3.42%1.3B | -0.12%5.92B | 3.45%1.68B | -3.52%1.34B | 6.56%5.93B | -7.59%1.38B | 3.37%1.53B | 13.48%1.63B | 20.29%1.39B |
| Depreciation and amortization | --1.32B | 7.06%1.14B | 4.98%4.47B | 5.79%1.1B | 7.37%1.06B | 15.33%4.26B | 16.82%1.15B | 17.66%1.09B | 13.21%1.04B | 13.40%990M |
| -Depreciation | --1.32B | 7.06%1.14B | 4.98%4.47B | 5.79%1.1B | 7.37%1.06B | 15.33%4.26B | 16.82%1.15B | 17.66%1.09B | 13.21%1.04B | 13.40%990M |
| Rent and land expenses | --1.45B | 2.39%1.37B | 3.40%5.44B | 4.98%1.37B | 5.19%1.34B | 5.30%5.26B | 5.75%1.34B | 7.37%1.34B | 4.82%1.31B | 3.25%1.27B |
| Other operating expenses | --1.93B | 8.24%1.95B | 3.39%7.32B | 6.43%1.84B | 9.51%1.8B | 19.87%7.08B | 23.15%2B | 22.60%1.71B | 18.06%1.73B | 15.32%1.64B |
| Operating profit | 2.99B | 3.28%3.05B | 12.89%12.28B | 7.98%2.8B | 20.40%2.96B | 20.06%10.88B | 25.53%3.13B | 20.91%2.7B | 19.77%2.59B | 13.18%2.46B |
| Net non-operating interest income (expenses) | -17M | 36.36%-14M | 29.25%-75M | 26.92%-19M | 24.14%-22M | -39.47%-106M | -20.00%-24M | -42.11%-27M | -36.84%-26M | -61.11%-29M |
| Non-operating interest income | --8M | 20.00%6M | 9.09%24M | 0.00%6M | 0.00%5M | -4.35%22M | -25.00%6M | 0.00%5M | 20.00%6M | 0.00%5M |
| Non-operating interest expense | --25M | -25.93%20M | -22.66%99M | -21.88%25M | -20.59%27M | 29.29%128M | 7.14%30M | 33.33%32M | 33.33%32M | 47.83%34M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 9M | 17M | -125.22%-115M | -79.17%5M | 0 | 3,700.00%456M | 7,620.00%386M | 283.33%46M | 700.00%24M | 0 |
| Less:Other special charges | ---9M | ---17M | 125.22%115M | ---- | ---- | -3,700.00%-456M | -7,620.00%-386M | -283.33%-46M | ---- | ---- |
| Other non-operating income (expenses) | 28M | -41.67%14M | -14.74%81M | -34.78%15M | -11.11%24M | -32.62%95M | -23.81%32M | -75.93%13M | 4.55%23M | 17.39%27M |
| Income before tax | 3B | 3.86%3.07B | 7.46%12.16B | 7.07%2.8B | 20.59%2.95B | 23.95%11.32B | 39.93%3.52B | 19.82%2.73B | 20.84%2.62B | 12.86%2.45B |
| Income tax | 714M | 3.89%935M | 19.05%3.25B | 1.79%854M | 14.50%900M | -6.83%2.73B | -72.64%226M | 21.10%878M | 21.77%839M | 14.08%786M |
| Net income | 2.29B | 3.85%2.13B | 3.77%8.91B | 9.57%1.95B | 23.47%2.05B | 38.49%8.59B | 94.91%3.3B | 19.22%1.86B | 20.41%1.78B | 12.30%1.66B |
| Net income continuous operations | --2.29B | 3.85%2.13B | 3.77%8.91B | 9.57%1.95B | 23.47%2.05B | 38.49%8.59B | 94.91%3.3B | 19.22%1.86B | 20.41%1.78B | 12.30%1.66B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 2.29B | 3.90%2.13B | 3.77%8.91B | 9.63%1.95B | 23.41%2.05B | 38.51%8.59B | 95.03%3.3B | 19.28%1.86B | 20.26%1.78B | 12.37%1.66B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.29B | 3.90%2.13B | 3.77%8.91B | 9.63%1.95B | 23.41%2.05B | 38.51%8.59B | 95.03%3.3B | 19.28%1.86B | 20.26%1.78B | 12.37%1.66B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 107.32 | 3.78%99.65 | 3.69%416.95 | 9.58%91.03 | 23.40%96.02 | 38.53%402.12 | 95.07%154.32 | 19.38%86.92 | 20.22%83.07 | 12.36%77.81 |
| Diluted earnings per share | 107.32 | 3.79%99.21 | 3.66%415.14 | 9.52%90.63 | 23.17%95.59 | 38.31%400.49 | 94.68%153.6 | 19.12%86.53 | 20.05%82.75 | 12.35%77.61 |
| Dividend per share | 0 | 0 | 31.82%58 | 30.00%26 | 0 | 10.00%44 | 20.00%24 | 0 | 0.00%20 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |